Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market
Holding RNA?
Track your performance easily

Avidity Biosciences (RNA) Financial Statements

543 Followers

Avidity Biosciences Financial Overview

Avidity Biosciences's market cap is currently ―. The company's EPS TTM is $-2.949; its P/E ratio is -16.32; Avidity Biosciences is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 3.54M$ 2.19M$ 2.82M$ 2.32M$ 2.23M
Gross Profit$ 3.54M$ 2.19M$ 2.82M$ 2.32M$ 2.23M
EBIT$ -77.19M$ -66.74M$ -52.36M$ -48.16M$ -51.23M
EBITDA$ -76.55M$ -66.13M$ -53.99M$ -49.77M$ -52.37M
Net Income Common Stockholders$ -68.86M$ -60.44M$ -52.36M$ -47.02M$ -51.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 915.87M$ 595.35M$ 542.58M$ 576.50M$ 118.71M
Total Assets$ 951.47M$ 628.55M$ 573.16M$ 610.78M$ 613.98M
Total Debt$ 9.15M$ 9.85M$ 10.58M$ 9.51M$ 477.69M
Net Debt$ -906.73M$ -585.50M$ -532.00M$ -566.99M$ 358.99M
Total Liabilities$ 120.58M$ 127.79M$ 55.70M$ 51.61M$ 55.06M
Stockholders Equity$ 830.92M$ 500.76M$ 517.47M$ 559.14M$ 558.91M
Cash Flow-
Free Cash Flow$ -71.30M$ 15.64M$ -37.69M$ -50.46M$ -50.78M
Operating Cash Flow$ -70.38M$ 16.50M$ -36.77M$ -49.84M$ -48.96M
Investing Cash Flow$ -32.75M$ 51.04M$ -31.48M$ 46.05M$ -195.68M
Financing Cash Flow$ 389.44M$ 31.89M$ 40.00K$ 38.97M$ 22.96M
Currency in USD

Avidity Biosciences Earnings and Revenue History

Avidity Biosciences Debt to Assets

Avidity Biosciences Cash Flow

Avidity Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis